Your browser doesn't support javascript.
loading
Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients.
Laskari, K; Tektonidou, M G; Katsiari, C; Athanassiou, P; Dimopoulou, D; Gerodimos, C; Salamaliki, C; Papagoras, C; Settas, L; Vassilopoulos, D; Voulgari, P V; Zakalka, M; Georgiadis, A; Gkoni, G; Daoussis, D; Dimitroulas, T; Iliou, C; Kallitsakis, I; Grika, E P; Mavragani, C; Pikazis, D; Raftakis, J; Sarikoudis, T; Kougkas, N; Soukera, D; Theodorou, E; Tsatsani, P; Tsiakou, E; Vlachoyiannopoulos, P; Vosvotekas, G; Sfikakis, P P.
Afiliação
  • Laskari K; Joint Rheumatology Program, NKUA Medical School, Athens, Greece. Electronic address: katerina_laskari@yahoo.gr.
  • Tektonidou MG; Joint Rheumatology Program, NKUA Medical School, Athens, Greece.
  • Katsiari C; Dept. of Rheumatology, Thessaly University, Larissa, Greece.
  • Athanassiou P; Dept. of Rheumatology, St. Paul's Hospital, Thessaloniki, Greece.
  • Dimopoulou D; 4th Dept. of Internal Medicine, Aristotle University, Thessaloniki, Greece.
  • Gerodimos C; Private rheumatologist, Volos.
  • Salamaliki C; Dept. of Rheumatology, University of Patras, Patras.
  • Papagoras C; 1st Dept. of Internal Medicine, Democritus University of Thrace, Alexandroupolis.
  • Settas L; First Dept. of Internal Medicine, Rheumatology Section, Aristotle University, Thessaloniki, Greece.
  • Vassilopoulos D; Joint Rheumatology Program, NKUA Medical School, Athens, Greece.
  • Voulgari PV; Rheumatology Clinic, Department of Internal Medicine, University of Ioannina, Ioannina, Greece.
  • Zakalka M; First Dept. of Internal Medicine, Rheumatology Section, Aristotle University, Thessaloniki, Greece.
  • Georgiadis A; Private rheumatologist, Ioannina, Greece.
  • Gkoni G; Rheumatologist, Metropolitan Hospital, Athens, Greece.
  • Daoussis D; Dept. of Rheumatology, University of Patras, Patras.
  • Dimitroulas T; 4th Dept. of Internal Medicine, Aristotle University, Thessaloniki, Greece.
  • Iliou C; Private rheumatologist, Kozani, Greece.
  • Kallitsakis I; Private rheumatologist, Chania, Greece.
  • Grika EP; Rheumatology Clinic, Evangelismos Hospital, Athens, Greece.
  • Mavragani C; Joint Rheumatology Program, NKUA Medical School, Athens, Greece.
  • Pikazis D; Joint Rheumatology Program, NKUA Medical School, Athens, Greece.
  • Raftakis J; Rheumatology Clinic, Asklepion Hospital, Athens, Greece.
  • Sarikoudis T; Private rheumatologist, Kavala, Greece.
  • Kougkas N; Dept. of Rheumatology, Clinical Immunology and Allergy, University of Crete, Heraklion, Greece.
  • Soukera D; Private rheumatologist, Corinth, Greece.
  • Theodorou E; Dept. of Rheumatology, 251 Air Force General Hospital, Athens, Greece.
  • Tsatsani P; Dept. of Rheumatology, KAT General Hospital, Athens, Greece.
  • Tsiakou E; Private rheumatologist, Patras, Greece.
  • Vlachoyiannopoulos P; Joint Rheumatology Program, NKUA Medical School, Athens, Greece.
  • Vosvotekas G; Private rheumatologist, Thessaloniki, Greece.
  • Sfikakis PP; Joint Rheumatology Program, NKUA Medical School, Athens, Greece.
Semin Arthritis Rheum ; 51(1): 137-143, 2021 02.
Article em En | MEDLINE | ID: mdl-33383289
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Doença de Still de Início Tardio / Antirreumáticos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Doença de Still de Início Tardio / Antirreumáticos Idioma: En Ano de publicação: 2021 Tipo de documento: Article